Carotid artery calcification at the initiation of hemodialysis is a risk factor for cardiovascular events in patients with end-stage renal disease: A cohort study

BMC Nephrology

Volumn 12, Issue 1, 2011, Pages

  Nakayama, Masaru ^a   Ura, Yoriko ^a   Nagata, Masaharu ^b   Okada, Yasushi ^a   Sumida, Yoko ^a   Nishida, Kanako ^a   Ikeda, Hirofumi ^a   Kaizu, Yoshiki ^a  

^a NATIONAL HOSPITAL ORGANIZATION KYUSHU MEDICAL CENTER   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTERIAL WALL THICKNESS; ARTERY CALCIFICATION; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CAROTID ARTERY; CAROTID ARTERY CALCIFICATION; CEREBROVASCULAR DISEASE; COHORT ANALYSIS; COMMON CAROTID ARTERY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART DEATH; HEART FAILURE; HEMODIALYSIS; HUMAN; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; RETROSPECTIVE STUDY; SMOKING; CALCINOSIS; CAROTID ARTERY OBSTRUCTION; CHRONIC KIDNEY FAILURE; HEART MUSCLE ISCHEMIA; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PREVALENCE; PROPORTIONAL HAZARDS MODEL; RENAL REPLACEMENT THERAPY; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; CALCINOSIS; CAROTID STENOSIS; CEREBROVASCULAR DISORDERS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PREVALENCE; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS; RISK FACTORS;

EID: 80053979320     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-12-56     Document Type: Article

References (41)

1. Clinical epidemiology of cardiovascular disease in chronic renal disease. Foley RN, Parfrey PS, Sarnak MJ, Am J Kidney Dis 1998 32 Suppl 3 112 S119 9820470
2. Arteriosclerosis, vascular calcifications and cardiovascular disease in uremia. London GM, Marchais SJ, Guérin AP, Métivier F, Curr Opin Nephrol Hypertens 2005 14 525 531 10.1097/01.mnh.0000168336.67499.c0 16205470 (Pubitemid 41531842)
3. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Blacher J, Guérin AP, Pannier B, Marchais SJ, London GM, Hypertension 2001 38 938 942 10.1161/hy1001.096358 11641313 (Pubitemid 34258697)
4. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. London GM, Guérin AP, Marchais SJ, Métivier F, Pannier B, Adda H, Nephrol Dial Transplant 2003 18 1731 1740 10.1093/ndt/gfg414 12937218 (Pubitemid 37098542)
5. Impact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis. Matsuoka M, Iseki K, Tamashiro M, Fujimoto N, Higa N, Touma T, Takishita S, Clin Exp Nephrol 2004 8 54 58 10.1007/s10157-003- 0260-0 15067517 (Pubitemid 38508656)
6. A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients. Adragao T, Pires A, Lucas C, Birne R, Magalhaes L, Gonçalves M, Negrao AP, Nephrol Dial Transplant 2004 19 1480 1488 10.1093/ndt/gfh217 15034154 (Pubitemid 38786742)
7. Presence of abdominal aortic calcification is significantly associated with all-cause and cardiovascular mortality in maintenance hemodialysis patients. Okuno S, Ishimura E, Kitatani K, Fujino Y, Kohno K, Maeno Y, Maekawa K, Yamakawa T, Imanishi Y, Inaba M, Nishizawa Y, Am J Kidney Dis 2007 49 417 425 10.1053/j.ajkd.2006.12.017 17336703
8. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Block GA, Raggi P, Bellasi A, Kooienga L, Spiegel DM, Kidney Int 2007 71 438 441 10.1038/sj.ki.5002059 17200680
9. Prognostic Value of Aortic Stiffness and Calcification for Cardiovascular Events and Mortality in Dialysis Patients: Outcome of the Calcification Outcome in Renal Disease (CORD) Study. Verbeke F, Van Biesen W, Honkanen E, Wikström B, Jensen PB, Krzesinski JM, Rasmussen M, Vanholder R, Rensma PL, The CORD Study Investigators, Clin J Am Soc Nephrol 2011 6 153 159 10.2215/CJN.05120610 20829424
10. Hyperhomocysteinemia, diabetes mellitus, and carotid atherosclerosis independently increase atherosclerotic vascular disease outcome in Japanese patients with end-stage renal disease. Haraki T, Takegoshi T, Kitoh C, Kajinami K, Wakasugi T, Hirai J, Shimada T, Kawashiri M, Inazu A, Koizumi J, Mabuchi H, Clin Nephrol 2001 56 132 139 11522090 (Pubitemid 32707822)
11. Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease. Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar ME, London GM, Hypertension 1998 32 570 574 9740628 (Pubitemid 28429151)
12. Intima-media thickness of carotid artery predicts cardiovascular mortality in hemodialysis patients. Nishizawa Y, Shoji T, Maekawa K, Nagasue K, Okuno S, Kim M, Emoto M, Ishimura E, Nakatani T, Miki T, Inaba M, Am J Kidney Dis 2003 41 Suppl 1 76 S79 12612958
13. Prognostic value of ultrasonographic measurement of carotid intima media thickness in dialysis patients. Benedetto FA, Mallamaci F, Tripepi G, Zoccali C, J Am Soc Nephrol 2001 12 2458 2464 11675423 (Pubitemid 33021124)
14. Presence of calcified carotid plaque predicts vascular events: the Northern Manhattan Study. Prabhakaran S, Singh R, Zhou X, Ramas R, Sacco RL, Rundek T, Atherosclerosis 2007 195 197 e201 10.1016/j.atherosclerosis.2007.03. 044 17482197 (Pubitemid 47561969)
15. Carotid artery calcification and atherosclerosis at the initiation of hemodialysis in patients with end-stage renal disease. Sumida Y, Nakayama M, Nagata M, Nakashita S, Suehiro T, Kaizu Y, Ikeda H, Izumaru K, Clin Nephrol 2010 73 360 369 20420796
16. Calcified plaque is common in the carotid and femoral arteries of dialysis patients without clinical vascular disease. Savage T, Clarke AL, Giles M, Tomson CR, Raine AE, Nephrol Dial Transplant 1998 13 2004 2012 10.1093/ndt/13.8.2004 9719155 (Pubitemid 28356766)
17. Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: The strong heart study. Resnick HE, Lindsay RS, McDermott MM, Devereux RB, Jones KL, Fabsitz RR, Howard BV, Circulation 2004 109 733 739 10.1161/01.CIR.0000112642.63927.54 14970108 (Pubitemid 38222892)
18. Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Block GA, Spiegel DM, Ehrlich J, Mehta R, Lindbergh J, Dreisbach A, Raggi P, Kidney Int 2005 68 1815 1824 10.1111/j.1523-1755.2005.00600.x 16164659 (Pubitemid 43169927)
19. Carotid artery calcification on multislice detector-row computed tomography. Uwatoko T, Toyoda K, Inoue T, Yasumori K, Hirai Y, Makihara N, Fujimoto S, Ibayashi S, Iida M, Okada Y, Cerebrovasc Dis 2007 24 20 26 10.1159/000103112 17519540 (Pubitemid 47026137)
20. Vascular calcification in ex vivo carotid specimens: precision and accuracy of measurements with multi-detector row CT. Hoffmann U, Kwait DC, Handwerker J, Chan R, Lamuraglia G, Brady TJ, Radiology 2003 229 375 381 10.1148/radiol.2292021016 14526093 (Pubitemid 37310820)
21. Arterial calcification and pathology in uremic patients undergoing dialysis. Ibels LS, Alfrey AC, Huffer WE, Craswell PW, Anderson JT, Weil R, Am J Med 1979 66 790 796 10.1016/0002-9343(79)91118-5 443254 (Pubitemid 9189336)
22. Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Schwarz U, Buzello M, Ritz E, Stein G, Raabe G, Wiest G, Mall G, Amann K, Nephrol Dial Transplant 2000 15 218 223 10.1093/ndt/15.2.218 10648668 (Pubitemid 30064276)
23. Vascular calcification in chronic kidney disease. Goodman WG, London G, Amann K, Block GA, Giachelli C, Hruska KA, Ketteler M, Levin A, Massy Z, McCarron DA, Raggi P, Shanahan CM, Yorioka N, Vascular Calcification Work Group, Am J Kidney Dis 2004 43 572 579 10.1053/j.ajkd.2003.12.005 14981617 (Pubitemid 38298218)
24. Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins. Moe SM, O'Neill KD, Duan D, Ahmed S, Chen NX, Leapman SB, Fineberg N, Kopecky K, Kidney Int 2002 61 638 647 10.1046/j.1523-1755.2002.00170.x 11849407 (Pubitemid 34102607)
25. Carotid artery calcium: accuracy of a calcium score by computed tomography: an in vitro study with comparison to sonography and histology. Denzel C, Lell M, Maak M, Höckl M, Balzer K, Müller KM, Fellner C, Fellner FA, Lang W, Eur J Vasc Endvasc Surg 2004 28 214 220 (Pubitemid 38967277)
26. Progression of aortic arch calcification and all-cause and cardiovascular mortality in chronic hemodialysis patients. Ogawa T, Ishida H, Akamatsu M, Matsuda N, Fujiu A, Ito K, Ando Y, Nitta K, Int Urol Nephrol 2010 42 187 194 10.1007/s11255-009-9574-5 19430924
27. Association between calcification in the coronary arteries, aortic arch and carotid arteries: the Rotterdam study. Odink AE, van der Lugt A, Hofman A, Hunink MG, Breteler MM, Krestin GP, Witteman JC, Atherosclerosis 2007 193 408 413 10.1016/j.atherosclerosis.2006.07.007 16919637 (Pubitemid 47058105)
28. Coronary artery calcium score and coronary heart disease events in a large cohort of asymptomatic men and women. LaMonte MJ, FitzGerald SJ, Church TS, Barlow CE, Radford NB, Levine BD, Pippin JJ, Gibbons LW, Blair SN, Nichaman MZ, Am J Epidemiol 2005 162 421 429 10.1093/aje/kwi228 16076829 (Pubitemid 41191427)
29. Arterial stiffening and vascular calcifications in end-stage renal disease. Guérin AP, London GM, Marchais SJ, Métivier F, Nephrol Dial Transplant 2000 15 1014 1021 10.1093/ndt/15.7.1014 10862640 (Pubitemid 30410374)
30. Impact of aortic stiffness on survival in end-stage renal disease. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM, Circulation 1999 99 2434 2439 10318666 (Pubitemid 29218240)
31. Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Guérin AP, Blacher J, Pannier B, Marchais SJ, Safar ME, London GM, Circulation 2001 103 987 992 11181474 (Pubitemid 32183805)
32. Pulse pressure and risk of total mortality and cardiovascular events in patients on chronic hemodialysis. Tozawa M, Iseki K, Iseki C, Takishita S, Kidney Int 2002 61 717 726 10.1046/j.1523-1755.2002.00173.x 11849415 (Pubitemid 34102615)
33. Vascular calcifications: pathogenesis, management, and impact on clinical outcomes. Cannata-Andía JB, Rodríguez-García M, Carrillo-Lápez N, Naves-Díaz M, Díaz-Lápez B, J Am Soc Nephrol 2006 17 Suppl 3 267 S273 17130273
34. Association of serum phosphate with vascular and valvular calcification in moderate CKD. Adeney KL, Siscovick DS, Ix JH, Seliger SL, Shlipak MG, Jenny NS, Kestenbaum BR, J Am Soc Nephrol 2009 20 381 387 10.1681/ASN.2008040349 19073826
35. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM, J Am Soc Nephrol 2004 15 2208 2218 10.1097/01.ASN.0000133041.27682.A2 15284307 (Pubitemid 39031360)
36. Predictors and consequences of altered mineral metabolism: the Dialysis Outcomes and Practice Patterns Study. Young EW, Albert JM, Satayathum S, Goodkin DA, Pisoni RL, Akiba T, Akizawa T, Kurokawa K, Bommer J, Piera L, Port FK, Kidney Int 2005 67 1179 1187 10.1111/j.1523-1755.2005.00185.x 15698460 (Pubitemid 41623345)
37. Serum phosphate levels and mortality risk among people with chronic kidney disease. Kestenbaum B, Sampson JN, Rudser KD, Patterson DJ, Seliger SL, Young B, Sherrard DJ, Andress DL, J Am Soc Nephrol 2005 16 520 528 10.1681/ASN.2004070602 15615819 (Pubitemid 41725150)
38. The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer. Russo D, Miranda I, Ruocco C, Battaglia Y, Buonanno E, Manzi S, Russo L, Scafarto A, Andreucci VE, Kidney Int 2007 72 1255 1261 10.1038/sj.ki.5002518 17805238 (Pubitemid 350059663)
39. Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Chertow GM, Burke SK, Raggi P, Treat to Goal Working Group, Kidney Int 2002 62 245 252 10.1046/j.1523-1755.2002.00434.x 12081584 (Pubitemid 34754068)
40. Systematic review of the clinical efficacy and safety of sevelamer in dialysis patients. Tonelli M, Wiebe N, Culleton B, Lee H, Klarenbach S, Shrive F, Manns B, Alberta Kidney Disease Network, Nephrol Dial Transplant 2007 22 2856 2866 10.1093/ndt/gfm421 17906326 (Pubitemid 350093462)
41. Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients. Suki WN, Zabaneh R, Cangiano JL, Reed J, Fischer D, Garrett L, Ling BN, Chasan-Taber S, Dillon MA, Blair AT, Burke SK, Kidney Int 2007 72 1130 1137 10.1038/sj.ki.5002466 17728707 (Pubitemid 47609037)